Safety and Efficacy of Nivolumab in Treating Oral Proliferative Verrucous Leukoplakia
Clinical trial NCT03692325 · COMPLETED
Trial details
- NCT number
- NCT03692325
- Sponsor
- Dana-Farber Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-12-05
- Primary completion
- 2022-09-01
- Enrollment
- 33
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.